Envestnet Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,349
| Closed | -$838K | – | 4600 |
|
|
2025
Q1 | $838K | Sell |
6,349
-125,313
| -95% | -$16.5M | ﹤0.01% | 3313 |
|
|
2024
Q4 | $11M | Sell |
131,662
-2,317
| -2% | -$194K | ﹤0.01% | 1574 |
|
|
2024
Q3 | $9.8M | Buy |
133,979
+7,520
| +6% | +$550K | ﹤0.01% | 1646 |
|
|
2024
Q2 | $8.66M | Sell |
126,459
-2,605
| -2% | -$178K | ﹤0.01% | 1651 |
|
|
2024
Q1 | $8.93M | Buy |
129,064
+721
| +0.6% | +$49.9K | ﹤0.01% | 1602 |
|
|
2023
Q4 | $9.19M | Buy |
128,343
+1,811
| +1% | +$130K | ﹤0.01% | 1497 |
|
|
2023
Q3 | $6.59M | Buy |
126,532
+45,616
| +56% | +$2.38M | ﹤0.01% | 1630 |
|
|
2023
Q2 | $5.12M | Buy |
80,916
+7,869
| +11% | +$498K | ﹤0.01% | 1691 |
|
|
2023
Q1 | $3.96M | Buy |
73,047
+16,192
| +28% | +$877K | ﹤0.01% | 1771 |
|
|
2022
Q4 | $3.01M | Sell |
56,855
-2,080
| -4% | -$110K | ﹤0.01% | 1899 |
|
|
2022
Q3 | $2.74M | Buy |
58,935
+55,308
| +1,525% | +$2.57M | ﹤0.01% | 1887 |
|
|
2022
Q2 | $207K | Buy |
+3,627
| New | +$207K | ﹤0.01% | 3582 |
|